Funding & Awards
Cure HHT’s Funding & Awards program supports research and collaborations to advance the science, diagnosis, and treatment of Hereditary Hemorrhagic Telangiectasia.
Funder: Cure HHT
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Typical grants range from $30,000–$50,000 per project; total annual funding varies.
Summary: Supports impactful research and collaborations to advance understanding and treatment of Hereditary Hemorrhagic Telangiectasia (HHT).
Description
The Funding & Awards program from Cure HHT is a central initiative aimed at catalyzing research, fostering collaborations, and accelerating advances in the understanding, diagnosis, and treatment of Hereditary Hemorrhagic Telangiectasia (HHT). Cure HHT is the only global organization solely dedicated to HHT, leveraging its unique position to bring together patient, scientific, and medical communities. The program strategically invests in high-impact research projects, young investigator awards, clinical trials, and educational efforts, with the goal of improving outcomes for HHT patients and their families.
